What is the QuicDNA test and how does it work?

The QuicDNA is a blood test that detects fragments of cancer DNA shed into the bloodstream, providing a rapid genetic reading of the cancer within two weeks.

How does the liquid biopsy blood test help cancer patients?

This test enables quicker diagnosis and the determination of personalized treatment plans, potentially saving lives by allowing timely intervention before patients deteriorate.

Is the QuicDNA test available for all cancer types?

Initially rolled out for later-stage lung cancer, the QuicDNA test is being expanded to include other cancer types such as colorectal and prostate cancer.

Home / Health / Liquid Biopsy Gives Cancer Patients a New Lease on Life

Liquid Biopsy Gives Cancer Patients a New Lease on Life

12 Feb

•

Summary

A simple blood test detects cancer DNA fragments in the bloodstream.
The QuicDNA test provides genetic cancer readings within two weeks.
This innovation enables quicker diagnosis and personalized cancer treatment.

Liquid Biopsy Gives Cancer Patients a New Lease on Life

Cutting-edge blood tests are revolutionizing cancer diagnosis and treatment, offering a lifeline to patients across Wales. Pat Grant, diagnosed with inoperable lung cancer, faced the grim prospect of never meeting her grandchild. However, participation in the Welsh QuicDNA trial led to a diagnosis that indicated her cancer could respond to specific medication. This innovation allowed her to regain strength and celebrate her grandchild's first birthday.

Similarly, Craig Maxwell, diagnosed with stage 4 lung cancer, experienced immense difficulty in obtaining a tumor sample for diagnosis. His subsequent fundraising efforts supported the QuicDNA project, which utilizes "liquid biopsies" – simple blood tests detecting cancer DNA fragments. This method provides rapid genetic readings within two weeks, significantly accelerating treatment decisions and improving patient outcomes.